NASDAQ
No price data available for this timeframe.
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.
Open
$0.46
Previous Close
$0.46
Day High
$0.46
Day Low
$0.46
52 Week High
$3.42
52 Week Low
$0.30